Search For "glenmark"
COVID-19: Glenmark's Favipiravir drug shows encouraging results in Phase 3
Updated : 5 years, 7 months ago IST
New Delhi [India], July 22 (ANI): Domestic pharma giant Glenmark pharmaceuticals on Thursday announced the positive outcomes from a Phase 3 clinical trial conducted across seven clinical sites in India, where COVID-19 patients administered with Favipiravir reported faster clinical cure an
Read More
Glenmark responds to DCGI letter seeking clarification on Fabiflu
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] July 21 (ANI/PRNewswire): In response to the DCGI letter seeking clarification on FabiFlu, Glenmark Pharmaceuticals Ltd, a research-led, integrated global pharmaceutical company, has responded back. Please click the link below, to access the response letter.
Read More
DCGI seeks clarification from Glenmark on its anti-viral favipiravir for u
Updated : 5 years, 8 months ago IST
New Delhi [India], July 19 (ANI): The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on COVID-19 patients with comorbidities.
Read More
Glenmark commences 1000 patients Post Marketing Surveillance study with CO
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu® to closely monitor the efficacy and safety of the drug in
Read More
Glenmark cuts COVID-19 drug Favipiravir price by 27 pc
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI): Glenmark Pharmaceuticals said on Monday it has cut the price of its anti-viral drug Favipiravir under the brand name FabiFlu for treatment of patients with mild to moderate COVID-19 by 27 per cent to Rs 75 per tablet.
Read More
Fitch affirms Glenmark Pharmaceuticals at BB, withdraws proposed bond rati
Updated : 5 years, 8 months ago IST
Singapore, July 10 (ANI): Fitch Ratings has affirmed Glenmark Pharmaceuticals' long-term issuer default rating at BB with a stable outlook.
Read More
Hindustan Unilever completes acquisition of VWash from Glenmark Pharma
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 26 (ANI): Fast-moving consumer goods major Hindustan Unilever Ltd (HUL) said on Friday it has completed the acquisition of intimate hygiene brand VWash from Glenmark Pharmaceuticals.
Read More
Sensex closes 180 points up, Glenmark Pharma jumps 27 pc
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Equity benchmark indices wiped out early gains but closed over half a per cent higher on Monday led by gains in banking, pharma and metal stocks.
Read More
Glenmark, Cipla stocks surge after nod to launch drugs for mild-to-moderat
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 22 (ANI): Glenmark Pharmaceuticals' share price surged 30 per cent on Monday to Rs 531.80 per unit after it became the first pharmaceutical company in India to receive regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to
Read More
Anti-viral drug Favipiravir shows clinical improvement in mild, moderate C
Updated : 5 years, 8 months ago IST
New Delhi [India], June 20 (ANI): Domestic pharmaceuticals Glenmark on Saturday informed that their antiviral drug -- Favipiravir -- has shown clinical improvement of up to 88 per cent in mild to moderate COVID-19 cases, including those with co-morbidities.
Read More
Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' i
Updated : 5 years, 9 months ago IST
New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral drug favipiravir for "restricted emergency use" in mild to moderate cases of COVID-19, a senior government official confirmed to ANI.
Read More
Glenmark to start new phase 3 clinical trial for hospitalised patients of
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India], May 26 (ANI): Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential Covid-19 treatment strategy.
Read More